Change of Name

Recorded: 2023-05-23 Pages: 3

Assignor

ANTIGEN EXPRESS, INC

Executed: 2019-12-27

Assignee

NUGENEREX IMMUNO-ONCOLOGY, INC.

450 CENTURY PKWY, SUITE 250, ALLEN, TEXAS, 75013

Covered Property (1)

Ii-Key/Her-2/Neu Hybrid Cancer Vaccine

Patent: 7,935,350 →

Application: 12/002,083 →

Publication: US 2009/0060936

Related Assignments (1)

Other recorded transfers of the patent in this record — the chain of ownership.